24 November 2023
A recent study led by OUCRU researchers highlighted the factors associated with the number of visits to one tertiary public hospital (Hospital for Tropical Diseases in Ho Chi Minh City) that serves as the referral clinic for two-thirds of Vietnam for Hepatitis C virus treatment.
23 November 2023
OUCRU are tackling the global health threat of Antimicrobial Resistance – a silent pandemic claiming millions of lives yearly. Learn about our collaborative research, our interventions in local hospitals, and our ongoing efforts to combat AMR.
23 November 2023
Antimicrobial resistance (AMR) is a global health crisis that jeopardizes our ability to effectively treat infections caused by bacteria, viruses, and parasites. To address this urgent issue, OUCRU has been implementing projects involving the youth and empowering young individuals to take action and make a difference.
22 November 2023
As part of the global efforts to raise awareness about Antimicrobial Resistance (AMR) during World AMR Awareness Week, OUCRU Nepal has been actively engaging in public outreach activities since 2016. These initiatives aim to educate and empower individuals to take action in preventing the spread of AMR and promote responsible antibiotic use in the country.
21 November 2023
At OUCRU, we are committed to raising awareness about antimicrobial resistance in the communities we work with. To fulfil our commitment, OUCRU’s Public and Community Engagement team has organised several activities and projects across our sites. The aim has been to educate and empower individuals to take action in preventing the spread of AMR by promoting responsible antibiotic use.
Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor
19 November 2023
AMR has been linked to close to 5 million deaths annually. We need urgent global action to counter antimicrobial resistance, but current efforts focus on solutions developed in high-income settings. If we want people to become less dependent on antibiotics, we must address the factors that create dependency on antibiotics in the first place. The solution we are working towards is fair and inclusive; it respects people and their traditions while also benefiting human health, animal welfare and the natural environment.
1 November 2023
OUCRU will be a part of a new initiative aimed at developing a strategic roadmap for Ho Chi Minh City to become a regional Health Innovation Hub. The project, supported by a £75,000 grant from the UK Government, is a strategic move to transform Ho Chi Minh City into ASEAN's leading health innovation centre.
24 October 2023
In collaboration with Ho Chi Minh City's healthcare sector, OUCRU has successfully identified the primary agent causing the outbreak of pink eye disease. Testings revealed an unexpected finding: enterovirus was the primary agent, contrary to previous reports from Vietnam wherein adenovirus was the culprit.
13 October 2023
The ACT HIV trial conducted by NDM’s Oxford University Clinical Research Unit (OUCRU), investigated the effectiveness of dexamethasone in reducing death, disability, and other complications in HIV-positive adults with tuberculous meningitis.
10 October 2023
On October 7th, we had the privilege of hosting a live webinar together with the Vietnamese Psychotherapy Association (VnPA) and Medisetter, titled “Mental Healthcare for Carers: We Support the Supporters!” in honour of World Mental Health Day 10th October 2023.
9 October 2023
October 10th is World Mental Health Day. This year, the global theme, “Our Minds, Our Rights,” emphasises the universal right to access mental healthcare services as part of basic healthcare, which is considered one of our fundamental human rights.
26 September 2023
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in Plasmodium vivax malaria endemic countries.
19 September 2023
We are delighted to announce that three of our researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
31 August 2023
A study coordinated by NDM researchers published in BMC Medicine explores the factors predicting higher mortality in pregnant women with severe malaria and describes how severe falciparum malaria in pregnancy affects foetal health and mortality.
22 August 2023
A new study published in The Lancet Global Health highlights the devastating impact of the COVID-19 pandemic on tuberculosis (TB) control in Indonesia, the nation with the second highest TB burden globally and the second highest burden of COVID-19 in the Asian region.
16 August 2023
The ABACUS II Consortium, which includes the Medicine Quality Research Group, published a new viewpoint calling for the standardisation of antibiotics appearance and better information around usage. Changes to the appearance of antibiotic medicines could help avoid confusion and reduce misuse. These measures could help reduce antibiotic resistance, an urgent and global problem that is growing every year.
11 August 2023
Four major clinical trial networks, including Oxford University Clinical Research Unit, The Global Health Network, hosted by NDM’s Centre for Tropical Medicine and Global Health, based in low-resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (GCTC) to enhance clinical research in low-resource settings.
World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with Hepatitis C
28 July 2023
According to the World Health Organisation, 10-15% of Vietnam’s population is estimated to have viral hepatitis, including 1,07 million people who have Hepatitis C. Over 90% of those who have Hepatitis C are not aware of their positive status. OUCRU, the Hospital for Tropical Diseases (Ho Chi Minh City), and Vietnam’s National Hospital for Tropical Diseases (Hanoi) have been collaborating on Hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy for Hepatitis C.
Opportunities and Challenges in Applying Artificial Intelligence and Digital Health Technologies in Viet Nam
14 July 2023
Digital health and artificial intelligence have the potential to transform healthcare, making health care management more efficient and accessible. However, a new paper by Ho Quang Chanh et al, detailed why engagement with policymakers, local patients and healthcare workers, and integrating with local systems and practice are crucial to ensure that digital health technologies can thrive in low- and middle-income settings.
5 July 2023
The OUCRU Indonesia project, “Improving access to skincare through teledermatology in Eastern Indonesia”, is one of five laureates selected this year from 193 applications in 66 countries by an independent scientific committee of five dermatologists and ILDS board members.
23 May 2023
We are delighted to announce that four of our researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
23 May 2023
OUCRU, in collaboration with Dak Lak’s Department of Health and Centre for Disease Control (CDC), developed a training programme to enhance the capacity of commune vaccine staff, with a particular focus on supporting their communication about the vaccines and vaccination process.
Global team of humanities and social science researchers to explore Just Transitions for antimicrobial resistance
9 May 2023
'Just Transitions to mitigate antimicrobial resistance' is a multidisciplinary social science and humanities programme funded by the British Academy. Led by Dr Sonia Lewycka and Professor Phaik Yeong Cheah, its team of 20 researchers will convene global and regional dialogues, engaging with key stakeholders to co-create equitable and sustainable solutions to manage antimicrobial resistance.
5 May 2023
Vaccines are the most effective and affordable way to prevent diseases. The pandemic led to a lag in immunisation for essential vaccines – 25 million children worldwide missed out on vaccination in 2021, according to WHO. At OUCRU, in addition to research and collaborations on various vaccine projects, we are committed to public and community engagement and education around vaccines. Look at some engagement projects that help raise awareness about vaccination and build the capacity for frontline healthcare workers, especially in rural areas.
6 April 2023
OUCRU study explored why participants made decisions to participate in clinical trials and outlined ways to improve participants’ experience during the informed consent process.
5 April 2023
Funded by Wellcome, ACORN (A Clinically-Oriented antimicrobial Resistance Network) is an AMR surveillance project that collects clinical and microbiology data on community- and hospital-acquired infections. ACORN will assess the impacts of AMR on the duration of hospitalisation and mortality in collaboration with the WHO Global AMR Surveillance System (GLASS) team.
Improving access to care for people in Vietnam impacted by Hepatitis C: dissemination workshop to share findings of OUCRU’s community-based participatory research
22 March 2023
OUCRU and HCMC Hospital for Tropical Diseases host a one-day research dissemination workshop for policy, healthcare, community, and research stakeholders. The workshop is the culmination of an OUCRU project: “Community-based participatory research to promote engagement with underserved communities at risk of Hepatitis C virus in Ho Chi Minh City, Vietnam”.
The journey of dreams, improving engagement with underserved populations at risk for Hepatitis C in Vietnam.
22 March 2023
OUCRU Public and Community Engagement team produced a video based on their project “Community-based participatory research to promote engagement with underserved communities at risk of Hepatitis C virus in Ho Chi Minh City, Vietnam”. This video was made by community members of the community-based participatory research to the project. The video is in Vietnamese with English subtitles
1 March 2023
The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.
7 February 2023
DART (Dengue Advanced Readiness Tools), is a new project supported by Wellcome to use climate data to better predict and prepare for infectious diseases outbreaks.
23 December 2022
Photographs have the power to inform and engage viewers. Earlier this year, The Lancet invited submissions for Highlights, the publication’s annual photography competition. Highlights 2022 featured 14 winning photographs telling stories from a wide variety of health-related topics that captured the world’s attention in 2022. One of the powerful images selected was from Pearl Gan, OUCRU’s Photographer in Residence.
20 December 2022
The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.
18 November 2022
OUCRU Indonesia launches a new exhibition by photographer Yoppy Pieter based in Jakarta, Indonesia. This exhibition documents, through a series of intimate and beautiful images, the invisible burden of leprosy and other skin diseases in Sumba, an island in Nusa Tenggara Timor province, Indonesia.
18 November 2022
November 18 – 24 is World Antimicrobial Awareness Week. Antimicrobial resistance has been a key focus in OUCRU’s research for many years. Our objective is to understand and improve antimicrobial use and antimicrobial resistance in agriculture, the community, and hospitals. Our approach is interdisciplinary – led by a number of OUCRU’s research groups and public engagement teams.
25 October 2022
OUCRU’s Public and Community Engagement team develops training and resources on the topic of stress management and communication skills. Run by the Public and Community Engagement team, the Youth Ambassadors programme also links young people to medical research that impacts their lives and connects researchers to the health issues that young people care about.
OUCRU presents a new virtual exhibition: Digital Diaries, Voices from the Pandemic, COVID-19 experiences in Asia
13 September 2022
This online exhibition showcases short films and photographs created by health-care workers and community members and documents the socio-cultural impact of the COVID-19 pandemic in Indonesia, Nepal and Vietnam.
World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with hepatitis C
28 July 2022
Today is World Hepatitis Day. OUCRU and hospitals in Ho Chi Minh City and Hanoi have been collaborating on hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy. OUCRU’s social science and public engagement teams are currently working with underrepresented groups to create community-led strategies to link care and treatment for populations at risk for viral hepatitis. Our aim is to have a more significant impact on the treatment strategy and access to care for patients with hepatitis C in Vietnam and worldwide in the future.
Prof Guy Thwaites co-authored WHO’s report on antibacterial agents in preclinical & clinical development
5 July 2022
OUCRU’s Director, Professor Guy Thwaites, has recently contributed to an analysis of antibacterial agents in preclinical and clinical development by the World Health Organisation (WHO), as part of the WHO advisory group on research and development of antibacterial treatments.
28 June 2022
OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.
21 June 2022
Healthcare workers and community members in Indonesia, Nepal and Vietnam have been documenting their personal experiences of Covid-19. They have each made their own ‘digital diary’, using a range of creative tools and with technical support from the project team. These diaries form part of the SPEAR project: exploring the experiences and impacts of COVID-19 for healthcare workers and vulnerable communities.
21 June 2022
Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.
First-of-its-kind study found equine antitoxin is safe and effective for the treatment of tetanus in adults
24 May 2022
A first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone.
26 April 2022
The Eijkman Oxford Clinical Research Unit in Indonesia and Sumba Foundation collaborated with photographer Yoppy Pieter to express the human face of leprosy in Sumba, a remote island in eastern Indonesia. The project aimed to visualize the story of leprosy and raise awareness of this debilitating and heavily stigmatised disease
24 March 2022
Each year on 24 March, World TB Day is commemorated to raise awareness of this devastating and deadly disease. The theme for this year’s World TB Day is “Invest to End TB. Save Lives”, conveying the urgent need to invest resources to ramp up the fight against TB and achieve the commitments to end TB made by global leaders.
TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS
22 March 2022
A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.